/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Labopharm Inc.\n \n\n\n\n\n
Nov 23 8:24 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 20, 2009 7:04 AM EST
\n\n \n Labopharm to present at Dundee Emerging Growth Summit - CNW\n \n \n
\n\n Nov 20, 2009 7:01 AM EST
\n\n \n Labopharm fera une présentation à la conférence Dundee sur la croissance émergente - CNW\n \n \n
\n\n Nov 20, 2009 7:00 AM EST
\n\n \n Labopharm to present at Dundee Emerging Growth Summit - PR Newswire\n \n \n
\n\n Nov 10, 2009 12:46 PM EST
\n\n \n La formulation innovante de trazodone de Labopharm fait l'objet d'une publication dans une revue médicale - CNW\n \n \n
\n\n Nov 10, 2009 12:45 PM EST
\n\n \n Labopharm's novel trazodone formulation subject of publication in peer-reviewed medical journal - CNW\n \n \n
\n\n Nov 10, 2009 12:45 PM EST
\n\n \n Labopharm's novel trazodone formulation subject of publication in peer-reviewed medical journal - PR Newswire\n \n \n
\n\n Nov 06, 2009 8:36 AM EST
\n\n \n Labopharm Reports Results for Third Quarter Fiscal 2009 - CNW\n \n \n
\n
\n\n");